Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating benign prostatic hyperplasia

A technology of benign prostatic hyperplasia and composition, which is applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., and can solve problems such as large side effects and affecting prognosis

Inactive Publication Date: 2016-05-04
JINAN XINGYI MEDICAL TECH
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The conventional western medicine Qianliekang Tablets can relieve the clinical symptoms of the patients to a certain extent, but long-term use of the medicine will produce relatively large side effects and affect the prognosis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Embodiment 1: The pharmaceutical composition for the treatment of benign prostatic hyperplasia and its preparation method

[0034] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating benign prostatic hyperplasia are: wild fire rope 4235g wolf's clove 3140g leprosyrin C264g Agrimony lactone 155g;

[0035] Preparation:

[0036](1) According to the proportion of raw materials, take wild fire rope, wolfschinum, liquiritigenin C, and agrimony lactone, mix them evenly, use ethanol with a concentration of 17% by weight as a solvent, and extract them by warm soaking at 26°C. The number of extraction times is 14 times, each extraction time is 24 hours, each time the amount of solvent is 25 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, the extract A recovers ethanol, concentrates to a relative density of 1.05, and filters , the medicinal solution passes through the SP825 ...

Embodiment 2

[0039] Embodiment 2: the pharmaceutical composition for the treatment of benign prostatic hyperplasia and its preparation method

[0040] The composition and parts by weight of the raw materials of the pharmaceutical composition for treating benign prostatic hyperplasia are: wild fire rope 4230g Osmanthus fragrans 3150g leprosyrrhizin C260g Agrimony lactone 158g;

[0041] Preparation:

[0042] (1) According to the proportion of raw materials, take wild fire rope, wolfschinum, liquiritigenin C, and agrimony lactone, mix them evenly, use ethanol with a concentration of 17% by weight as a solvent, and extract them by warm soaking at 26°C. The number of extraction times is 14 times, each extraction time is 24 hours, each time the amount of solvent is 25 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, the extract A recovers ethanol, concentrates to a relative density of 1.05, and filters , the medicinal solution passes through the...

Embodiment 3

[0045] Embodiment 3: the pharmaceutical composition for the treatment of benign prostatic hyperplasia and its preparation method

[0046] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating benign prostatic hyperplasia are: wild fire rope 4240g Osmanthus fragrans 3130g leprosyrin C268g agrimile lactone 152g;

[0047] Preparation:

[0048] (1) According to the proportion of raw materials, take wild fire rope, wolfschinum, liquiritigenin C, and agrimony lactone, mix them evenly, use ethanol with a concentration of 17% by weight as a solvent, and extract them by warm soaking at 26°C. The number of extraction times is 14 times, each extraction time is 24 hours, each time the amount of solvent is 25 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, the extract A recovers ethanol, concentrates to a relative density of 1.05, and filters , the medicinal solution passes through the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a medicine composition for treating benign prostatic hyperplasia and a preparing method of the medicine composition. The medicine composition is prepared from inner roots of grewia lantsangensis Hu, whole grass of Dicranopteris linearis (Burm.f.) Underw., glepidotin C and agrimonolide according to a proportion. The medicine composition can be prepared into various dosage forms according to conventional preparation technologies, and is significant in treatment effect when used for treating benign prostatic hyperplasia.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating benign prostatic hyperplasia and a preparation method thereof. Background technique [0002] Benign prostatic hyperplasia (BPH) is a clinically common male disease, mostly in the elderly, and the incidence of this disease has been increasing year by year in recent years. The pathogenesis of the disease is complex, and there is no unified conclusion in clinical practice. According to the syndrome differentiation method of traditional Chinese medicine, it is classified into the category of "addiction closed", and the disease starts from bladder squint. Relevant data show that the gasification function of the bladder directly affects the smooth discharge of urine, and the gasification function of the bladder is closely related to the gasification of the kidneys. Due to the weakness of kidney qi and the deficiency of a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/185A61P13/08A61K31/365A61K31/352
CPCA61K36/185A61K9/2031A61K9/2059A61K9/4866A61K31/352A61K31/365A61K36/11A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2236/55
Inventor 不公告发明人
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com